Icm Asset Management Lifted Position in Destination Xl Group (DXLG); Essex Investment Management Co Has Cut Corcept Therapeutics (CORT) Holding as Market Valuation Rose

February 12, 2018 - By Maria Brooks

Essex Investment Management Co Llc decreased its stake in Corcept Therapeutics Inc (CORT) by 19.73% based on its latest 2017Q3 regulatory filing with the SEC. Essex Investment Management Co Llc sold 74,745 shares as the company’s stock rose 42.01% with the market. The hedge fund held 304,101 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.87M, down from 378,846 at the end of the previous reported quarter. Essex Investment Management Co Llc who had been investing in Corcept Therapeutics Inc for a number of months, seems to be less bullish one the $1.72 billion market cap company. The stock increased 3.08% or $0.45 during the last trading session, reaching $15.04. About 1.83 million shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since February 12, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

Icm Asset Management Inc increased its stake in Destination Xl Group Inc. (DXLG) by 75.13% based on its latest 2017Q3 regulatory filing with the SEC. Icm Asset Management Inc bought 430,506 shares as the company’s stock declined 28.36% while stock markets rallied. The institutional investor held 1.00 million shares of the consumer services company at the end of 2017Q3, valued at $1.91 million, up from 573,026 at the end of the previous reported quarter. Icm Asset Management Inc who had been investing in Destination Xl Group Inc. for a number of months, seems to be bullish on the $110.65 million market cap company. The stock increased 1.11% or $0.025 during the last trading session, reaching $2.275. About 21,775 shares traded. Destination XL Group, Inc. (NASDAQ:DXLG) has declined 46.67% since February 12, 2017 and is downtrending. It has underperformed by 63.37% the S&P500.

Among 2 analysts covering Destination XL Group (NASDAQ:DXLG), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Destination XL Group had 6 analyst reports since August 20, 2015 according to SRatingsIntel. The stock has “Buy” rating by Brean Capital on Thursday, August 20. On Sunday, August 30 the stock rating was maintained by Sterne Agee CRT with “Buy”. Zacks upgraded Destination XL Group, Inc. (NASDAQ:DXLG) on Monday, August 31 to “Hold” rating. The rating was initiated by Wunderlich on Tuesday, August 2 with “Buy”. The stock of Destination XL Group, Inc. (NASDAQ:DXLG) earned “Buy” rating by Brean Capital on Friday, August 28.

Essex Investment Management Co Llc, which manages about $740.27 million and $735.81M US Long portfolio, upped its stake in Home Depot Inc (NYSE:HD) by 35,212 shares to 77,732 shares, valued at $12.71M in 2017Q3, according to the filing. It also increased its holding in Delphi Automotive Plc (NYSE:DLPH) by 38,063 shares in the quarter, for a total of 96,741 shares, and has risen its stake in Seabridge Gold Inc (NYSE:SA).

Since December 8, 2017, it had 0 insider buys, and 3 sales for $415,899 activity.

Investors sentiment decreased to 1.96 in Q3 2017. Its down 0.47, from 2.43 in 2017Q2. It turned negative, as 13 investors sold CORT shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. Neuberger Berman Llc has 0% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT). Ami Asset Mngmt reported 527,515 shares or 0.72% of all its holdings. The New York-based Jpmorgan Chase & Co has invested 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). 151,282 are held by Gsa Ptnrs Ltd Liability Partnership. Hbk Investments Ltd Partnership has invested 0% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). 70,034 were accumulated by 1492. Comml Bank Of Montreal Can reported 27,161 shares. Paloma Mngmt accumulated 0.02% or 62,439 shares. 5,800 are owned by Pacad. Catalyst Advsrs Limited Liability accumulated 72,150 shares. Natixis holds 0% or 11,354 shares. The Pennsylvania-based Federated Investors Pa has invested 0.66% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Ubs Asset Mgmt Americas has 39,683 shares for 0% of their portfolio. Meeder Asset Mngmt has invested 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Pnc Fin Svcs Gp reported 305,179 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: